APA (7th ed.) Citation

Pereira, N. L., Cresci, S., Angiolillo, D. J., Batchelor, W., Capers, Q., Cavallari, L. H., . . . Tuteja, S. (2024). CYP2C19 genetic testing for oral P2Y12 inhibitor therapy: A scientific statement from the American Heart Association. Circulation, 150(6), . https://doi.org/10.1161/CIR.0000000000001257

Chicago Style (17th ed.) Citation

Pereira, Naveen L., et al. "CYP2C19 Genetic Testing for Oral P2Y12 Inhibitor Therapy: A Scientific Statement from the American Heart Association." Circulation 150, no. 6 (2024). https://doi.org/10.1161/CIR.0000000000001257.

MLA (9th ed.) Citation

Pereira, Naveen L., et al. "CYP2C19 Genetic Testing for Oral P2Y12 Inhibitor Therapy: A Scientific Statement from the American Heart Association." Circulation, vol. 150, no. 6, 2024, https://doi.org/10.1161/CIR.0000000000001257.